RxDoctor Payments Data

Joseph Starke, DO

Family Medicine · Saint Louis, MONPI 1922414465

Payments from drug & device makers

$585in general payments, 2019–2025

Across 28 payments — averaging $20.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$354
  • GSK$66
  • Amgen$61
  • Novo Nordisk$58
  • Pulmonx Corporation$22
  • Boehringer Ingelheim$19
  • plus $5 from 1 others

What the payments were for

  • Food & beverage$56697%
  • Education$193%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$585 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$156,508
Medicare patients
668
Services billed
3,938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban354$127,038
Trelegy ElliptaFluticasone/Umeclidin/Vilanter101$94,853
JardianceEmpagliflozin104$83,811
OzempicSemaglutide56$58,443
XareltoRivaroxaban179$56,506
MounjaroTirzepatide33$33,158
FingolimodFingolimod Hcl11$31,534
LinzessLinaclotide42$24,800
TrulicityDulaglutide20$24,620
ArexvyRsvpref3 Antigen/As01e/Pf54$16,857
JanuviaSitagliptin Phosphate24$16,304
FarxigaDapagliflozin Propanediol30$15,998
AptiomEslicarbazepine Acetate21$13,445
TradjentaLinagliptin18$12,242
EntrestoSacubitril/Valsartan19$12,051

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$66$139,088209 claims
Boehringer IngelheimJardiance, Tradjenta$19$96,053122 claims
Novo NordiskOzempic$58$58,44356 claims
AbbVieLinzess$354$24,80042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →